FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3741017018 | Lanadelumab only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3741018011 | Product containing only lanadelumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5568201000241113 | produit contenant seulement du lanadélumab sous forme parentérale | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lanadelumab only product in parenteral dose form | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Lanadelumab (substance) | true | Inferred relationship | Some | 1 | |
| Lanadelumab only product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Lanadelumab only product in parenteral dose form | Is a | Product containing only lanadelumab (medicinal product) | true | Inferred relationship | Some | ||
| Lanadelumab only product in parenteral dose form | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Lanadelumab only product in parenteral dose form | Is a | Lanadelumab-containing product in parenteral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely lanadelumab 150 milligram/1 milliliter conventional release solution for injection (clinical drug) | Is a | True | Lanadelumab only product in parenteral dose form | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set